CAT-4001 | |
Catabasis Pharmaceuticals, Inc. | |
Preclinical | |
0% (Same As Avg.) | |
Small Molecule | |
NF-Kappa B (nuclear factor kappa-light-chain-enhancer of activated B cells)^ NRF2 | |
New Molecular Entity (NME) | |
N/A |
Fiche créée le 26/11/2015 par Guillaume vue 2 fois.